Collectively, our findings implicate the ATM‐p53‐p21 signalling pathway as a potential molecular therapeutic target for prevention and treatment of age‐related intervertebral disc degeneration. The gene discussed is CDKN1A; the disease is Intervertebral disk degeneration.